Oregon Gov. Kate Brown recently passed Senate Bill 763, which was designed to prevent pharmaceutical sales representatives from marketing and selling higher-cost medications to providers when cheaper alternatives are available. The law requires representatives to obtain a license before promoting pharmaceutical products, as well as submit sample and spend disclosures to the state's Department of Consumer andBusiness Services (DCBS). SB 763 goes into effect January 1, 2022.
Policy & Medicine